84 related articles for article (PubMed ID: 12689412)
1. Salivary agglutinin inhibits HIV type 1 infectivity through interaction with viral glycoprotein 120.
Wu Z; Van Ryk D; Davis C; Abrams WR; Chaiken I; Magnani J; Malamud D
AIDS Res Hum Retroviruses; 2003 Mar; 19(3):201-9. PubMed ID: 12689412
[TBL] [Abstract][Full Text] [Related]
2. gp340 (SAG) binds to the V3 sequence of gp120 important for chemokine receptor interaction.
Wu Z; Golub E; Abrams WR; Malamud D
AIDS Res Hum Retroviruses; 2004 Jun; 20(6):600-7. PubMed ID: 15242536
[TBL] [Abstract][Full Text] [Related]
3. The N-terminal SRCR-SID domain of gp-340 interacts with HIV type 1 gp120 sequences and inhibits viral infection.
Wu Z; Lee S; Abrams W; Weissman D; Malamud D
AIDS Res Hum Retroviruses; 2006 Jun; 22(6):508-15. PubMed ID: 16796526
[TBL] [Abstract][Full Text] [Related]
4. An inducible HIV type 1 gp41 HR-2 peptide-binding site on HIV type 1 envelope gp120.
Alam SM; Paleos CA; Liao HX; Scearce R; Robinson J; Haynes BF
AIDS Res Hum Retroviruses; 2004 Aug; 20(8):836-45. PubMed ID: 15320988
[TBL] [Abstract][Full Text] [Related]
5. Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions.
Biorn AC; Cocklin S; Madani N; Si Z; Ivanovic T; Samanen J; Van Ryk DI; Pantophlet R; Burton DR; Freire E; Sodroski J; Chaiken IM
Biochemistry; 2004 Feb; 43(7):1928-38. PubMed ID: 14967033
[TBL] [Abstract][Full Text] [Related]
6. Surfactant protein D binds to human immunodeficiency virus (HIV) envelope protein gp120 and inhibits HIV replication.
Meschi J; Crouch EC; Skolnik P; Yahya K; Holmskov U; Leth-Larsen R; Tornoe I; Tecle T; White MR; Hartshorn KL
J Gen Virol; 2005 Nov; 86(Pt 11):3097-3107. PubMed ID: 16227233
[TBL] [Abstract][Full Text] [Related]
7. CD4 activation of HIV fusion.
Sattentau QJ
Int J Cell Cloning; 1992 Nov; 10(6):323-32. PubMed ID: 1281202
[TBL] [Abstract][Full Text] [Related]
8. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
9. Lateral diffusion of CD4 on the surface of a human neoplastic T-cell line probed with a fluorescent derivative of the envelope glycoprotein (gp120) of human immunodeficiency virus type 1 (HIV-1).
Pal R; Nair BC; Hoke GM; Sarngadharan MG; Edidin M
J Cell Physiol; 1991 May; 147(2):326-32. PubMed ID: 2040664
[TBL] [Abstract][Full Text] [Related]
10. Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells.
Mori T; Boyd MR
Antimicrob Agents Chemother; 2001 Mar; 45(3):664-72. PubMed ID: 11181340
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to the superantigenic site of HIV-1 gp120: hydrolytic and binding activities of the light chain subunit.
Nishiyama Y; Karle S; Planque S; Taguchi H; Paul S
Mol Immunol; 2007 Apr; 44(10):2707-18. PubMed ID: 17222909
[TBL] [Abstract][Full Text] [Related]
12. Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention.
Auwerx J; François KO; Covens K; Van Laethem K; Balzarini J
Virology; 2008 Dec; 382(1):10-9. PubMed ID: 18930512
[TBL] [Abstract][Full Text] [Related]
13. Mapping the Ig superantigen-binding site of HIV-1 gp120.
Goodglick L; Zevit N; Neshat MS; Braun J
J Immunol; 1995 Dec; 155(11):5151-9. PubMed ID: 7594524
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 gp120: a novel viral B cell superantigen.
Townsley-Fuchs J; Neshat MS; Margolin DH; Braun J; Goodglick L
Int Rev Immunol; 1997; 14(4):325-38. PubMed ID: 9186784
[TBL] [Abstract][Full Text] [Related]
15. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.
Wu L; Gerard NP; Wyatt R; Choe H; Parolin C; Ruffing N; Borsetti A; Cardoso AA; Desjardin E; Newman W; Gerard C; Sodroski J
Nature; 1996 Nov; 384(6605):179-83. PubMed ID: 8906795
[TBL] [Abstract][Full Text] [Related]
16. A conserved molecular action of native and recombinant Epap-1 in inhibition of HIV-1 gp120 mediated viral entry.
Roda Rani KP; Pelluru D; Kondapi AK
Arch Biochem Biophys; 2006 Dec; 456(1):79-92. PubMed ID: 17078922
[TBL] [Abstract][Full Text] [Related]
17. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids.
Delézay O; Hammache D; Fantini J; Yahi N
Biochemistry; 1996 Dec; 35(49):15663-71. PubMed ID: 8961929
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of the gp120 superantigen-binding site on human immunoglobulins.
Karray S; Juompan L; Maroun RC; Isenberg D; Silverman GJ; Zouali M
J Immunol; 1998 Dec; 161(12):6681-8. PubMed ID: 9862697
[TBL] [Abstract][Full Text] [Related]
19. Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies.
Xiang SH; Doka N; Choudhary RK; Sodroski J; Robinson JE
AIDS Res Hum Retroviruses; 2002 Nov; 18(16):1207-17. PubMed ID: 12487827
[TBL] [Abstract][Full Text] [Related]
20. A polyanion binding site on the CD4 molecule. Proximity to the HIV-gp120 binding region.
Parish CR; Low L; Warren HS; Cunningham AL
J Immunol; 1990 Aug; 145(4):1188-95. PubMed ID: 2380554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
